PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
24.63%
Revenue growth above 1.5x CX's 13.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
24.63%
Gross profit growth similar to CX's 23.58%. Walter Schloss would assume both firms track common industry trends.
24.63%
EBIT growth below 50% of CX's 89.85%. Michael Burry would suspect deeper competitive or cost structure issues.
24.63%
Operating income growth under 50% of CX's 70.77%. Michael Burry would be concerned about deeper cost or sales issues.
88.35%
Positive net income growth while CX is negative. John Neff might see a big relative performance advantage.
85.71%
Positive EPS growth while CX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
85.71%
Positive diluted EPS growth while CX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.42%
Share change of 1.42% while CX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.42%
Diluted share change of 1.42% while CX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
40.06%
10Y revenue/share CAGR above 1.5x CX's 9.37%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
40.06%
5Y revenue/share CAGR at 50-75% of CX's 58.59%. Martin Whitman would worry about a lagging mid-term growth trajectory.
5.43%
3Y revenue/share CAGR above 1.5x CX's 1.13%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.50%
3Y net income/share CAGR above 1.5x CX's 19.86%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.